Biohaven Ltd. — Director's Dealing 2026

Jan 8, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biohaven Ltd. (BHVN)
CIK: 0001935979
Period of Report: 2026-01-05

Reporting Person: Coric Vlad (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-05	Common Shares	M	14250	—	Acquired	1811398	Direct
2026-01-05	Common Shares	F	7430	$9.93	Disposed	1803968	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-05	Restricted Share Unit Award	$	M	14250	Disposed		Common Shares (14250)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	1195275	Indirect
Common Shares	740546	Indirect
Common Shares	109565	Indirect

Footnotes

F1: No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.

F2: These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: Each restricted share unit represents the contingent right to receive one common share of the Issuer.

F4: The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.

F5: Not applicable.